Trump’s Tariff Threat Sparks Fears for Ireland’s Pharma Sector
200% levy could hit critical export industry
Ireland’s pharmaceutical industry is bracing for potential disruption as former U.S. President Donald Trump threatens a 200% tariff on drug imports.
Analysts warn such a move could severely impact Ireland’s largest export sector, which relies heavily on access to the U.S. market.
Analysts warn such a move could severely impact Ireland’s largest export sector, which relies heavily on access to the U.S. market.
